Sort
64,565 grants matching “drug discovery”
Gene Network Identification and Integration (GNetii) Approach to Understanding the Biology Underlying HIV and Drug Abuse.
$631,522Eric O Johnson · Research Triangle Institute · R01 · FY2020 · DA
Identification of NNMT as a New Target to Treat Triple-negative Breast Cancer
$631,492Binhua P Zhou · University Of Kentucky · R01 · FY2025 · CA
Credentialing murine models for glioblastoma preclinical drug development
$631,422Christopher Ryan Miller · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Live-Cell Assays of ER and Golgi Enzyme Activities
$631,417John J Naleway · Marker Gene Technologies · R44 · FY2017 · GM
Reversible male contraception by inhibition of serine/threonine kinase 33
$631,413Martin M Matzuk · Baylor College Of Medicine · R01 · FY2025 · HD
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
$631,410Michael Berney · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Long acting biodegradable buprenorphine depots
$631,404Andrew Otte · Purdue University · UG3 · FY2023 · DA
CAREER: CDS&E: Theory, Models and Computer Simulation of Molecular Recognition Processes
$631,358Emilio Gallicchio · Cuny Brooklyn College · · FY2018 · MPS
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
$631,336Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Regulation of epithelial function using targeted nanowires
$631,322Michael H. Koval · Emory University · R01 · FY2022 · HL
Signal Transduction by Tyrosine Phosphorylation
$631,180Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2013 · CA
Discovery Proteomics Core
$631,148Tukiet T Lam · Yale University · P30 · FY2018 · DA
High content screening of Mycobacterium tuberculosis
$631,092Tanya Parish · Access To Advanced Health Institute · R01 · FY2018 · AI
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
$630,978Michael Berney · Albert Einstein College Of Medicine · R01 · FY2022 · AI
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
$630,978Michael Berney · Albert Einstein College Of Medicine · R01 · FY2023 · AI
Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease
$630,969Wanqing Liu · Wayne State University · R01 · FY2023 · ES
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
$630,959Molly A Hughes · University Of Virginia · R01 · FY2021 · AI
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)
$630,895Michael Benatar · University Of Miami School Of Medicine · U01 · FY2023 · NS
Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa
$630,864Myron E Essex · Harvard School Of Public Health · R01 · FY2007 · AI
Resources for Teleost Gene Duplicates and Human Disease
$630,812John Harvey Postlethwait · University Of Oregon · R01 · FY2019 · OD
Resources for Teleost Gene Duplicates and Human Disease
$630,812John Harvey Postlethwait · University Of Oregon · R01 · FY2020 · OD
Novel Screening Platform for Discovery of DUB Targeting Probes
$630,805Sara J Buhrlage · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Models of AT Deficiency Using Human Hepatocytes
$630,750Ira J. Fox · Washington University · P01 · FY2019 · DK
Medicinal Chemistry
$630,737Craig Lindsley · Vanderbilt University · U01 · FY2011 · MH
Research Education Core
$630,715Danielle Sheldon Rudes · George Mason University · U2C · FY2024 · DA